ASCO Annual Meeting
Annual Meeting of American Society of Clinical Oncology (ASCO)
Chicago, May 30 - June 3, 2008
Roche and its collaborators presented a large number of abstracts on its broad oncology portfolio at the Annual Meeting of American Society of Clinical Oncology (ASCO) in Chicago on May 30 - June 3. In order to assist you, Roche has prepared an ASCO planner providing an overview of oral and poster abstracts relevant to Roche and our partners, including indication of time and venue of the presentation.
- Pertuzumab with Herceptin shows impressive results in women with advanced HER2-positive breast cancer more...
- Benefits of Avastin in metastatic colorectal cancer further substantiated more...
- Second phase III study of Avastin plus chemotherapy shows improved progression-free survival in women with advanced HER2-negative breast cancer more...
Investor and Analysts briefing Sunday, 1st June, 2008
Investor and Analysts briefing Monday, 2nd June 2008